Cargando…
Systemic toxicity to betamethasone ointment
Topically applied betamethasone for actinic keratosis may trigger systemic side effects. Systemic side effects of topical betamethasone may completely resolve after discontinuation of the causative agent. A 59‐year‐old male patient with scalp actinic keratosis developed fatigue and the need to sleep...
Autores principales: | Aliyev, Rahim, Finsterer, Josef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495834/ https://www.ncbi.nlm.nih.gov/pubmed/32983466 http://dx.doi.org/10.1002/ccr3.2957 |
Ejemplares similares
-
Efficacy and Safety of Calcipotriol/Betamethasone Dipropionate Ointment for the Treatment of Trachyonychia: An Open-Label Study
por: Park, Jung-Min, et al.
Publicado: (2015) -
Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis: Gel, Foam, and Ointment
por: Rudnicka, Lidia, et al.
Publicado: (2021) -
A rare case of Acrodermatitis continua of Hallopeau successfully
treated with topical calcipotriol/betamethasone dipropionate ointment associated
with Jaccaud’s arthropathy: A case report
por: Ngo, Jennifer Lavina, et al.
Publicado: (2022) -
A Case of Darier’s Disease with a Novel Missense Mutation in ATP2A2 Successfully Treated with Calcipotriol/Betamethasone Dipropionate Two-Compound Ointment
por: Hagino, Teppei, et al.
Publicado: (2022) -
Detection of compound heterozygous variants in LPIN1 does not necessarily imply pathogenicity in a patient with rhabdomyolysis
por: Finsterer, Josef, et al.
Publicado: (2020)